Journal of Affective Disorders
Volume 126, Issue 1 , Pages 75-79 , October 2010

Access to weight loss counseling services among patients with bipolar disorder

  • David E. Goodrich

      Affiliations

    • VA Ann Arbor Health Services Research and Development Center of Excellence, Ann Arbor, MI, United States
    • ,
  • Zongshan Lai

      Affiliations

    • Department of Psychiatry, University of Michigan Medical School, United States
    • ,
  • Elaine Lasky

      Affiliations

    • Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States
    • ,
  • Amy R. Burghardt

      Affiliations

    • Department of Psychiatry, University of Michigan Medical School, United States
    • ,
  • Amy M. Kilbourne

      Affiliations

    • VA Ann Arbor Health Services Research and Development Center of Excellence, Ann Arbor, MI, United States
    • Department of Psychiatry, University of Michigan Medical School, United States
    • Corresponding Author InformationCorresponding author. VA Ann Arbor HSR&D (11H), 2215 Fuller Road, Ann Arbor, MI 48105, United States. Tel.: +1 734 761 2210; fax: +1 734 761 2617.

Received 11 November 2009 ,Accepted 16 February 2010.

References 

  1. American Diabetes AssociationAmerican Psychiatric AssociationAmerican Association of Clinical EndocrinologistsNorth American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596–601
  2. Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, Mccoll L, Mcniven J. Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes?. Psychiatr. Serv. 2007;58:233–239
  3. Balf G, Stewart TD, Whitehead R, Baker RA. Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective. Prim Care Companion J. Clin. Psychiatry. 2008;10:15–24
  4. Blow F, Mccarthy J, Valenstein M. Care in the VHA for veterans with psychosis: FY2005. In: Annual Report on Veterans with Psychoses. Ann Arbor, MI: Department of Veterans Affairs National Serious Mental Illness Treatment and Research Center; 2005;
  5. Citrome L, Vreeland B. Schizophrenia, obesity, and antipsychotic medications: what can we do?. Postgrad. Med. 2008;120:18–33
  6. Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv. Rev. Psychiatry. 2006;14:212–222
  7. Correll CU, Frederickson AM, Kane JM, Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar. Disord. 2008;10:788–797
  8. Fenn HH, Bauer MS, Altshuler L, Evans DR, Williford WO, Kilbourne AM, et al. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J. Affect. Disord. 2005;86:47–60
  9. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight?. Jama. 1999;282:1576–1578
  10. Goldstein BI, Fagiolini A, Houck P, Kupfer D. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders. 2009;11:657–662
  11. Gordon AJ, Maisto SA, Mcneil M, Kraemer KL, Conigliaro RL, Kelley ME, et al. Three questions can detect hazardous drinkers. J. Fam. Pract. 2001;50:313–320
  12. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008;32:675–692
  13. Kemp DE, Gao K, Ganocy SJ, Caldes E, Feldman K, Chan PK, et al. Medical and substance use comorbidity in bipolar disorder. J. Affect. Disord. 2009;116:64–69
  14. Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics. 2007;48:412–417
  15. Kilbourne AM, Post EP, Bauer MS, Zeber JE, Copeland LA, Good CB, et al. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. J. Affect. Disord. 2007;102:145–151
  16. Kilbourne AM, Rofey DL, Mccarthy JF, Post EP, Welsh D, Blow FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord. 2007;9:443–452
  17. Kilbourne AM, Lasky E, Pincus HA, Good CB, Cooley S, Basavaraju A, et al. The Continuous Improvement for Veterans in Care: Mood Disorders (CIVID-MD) Study, a VA-academic partnership. Psychiatr. Serv. 2008;59:483–485
  18. Mcintyre RS. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey. J. Clin. Psychiatry. 2009;70(Suppl 3):5–11
  19. Powell LH, Calvin JE, Calvin JE. Effective obesity treatments. Am. Psychol. 2007;62:234–246
  20. Sciamanna CN, Tate DF, Lang W, Wing RR. Who reports receiving advice to lose weight? Results from a multistate survey. Arch. Intern. Med. 2000;160:2334–2339
  21. Simkin-Silverman LR, Gleason KA, King WC, Weissfeld LA, Buhari A, Boraz MA, et al. Predictors of weight control advice in primary care practices: patient health and psychosocial characteristics. Prev. Med. 2005;40:71–82
  22. Ussher M, Stanbury L, Cheeseman V, Faulkner G. Physical activity preferences and perceived barriers to activity among persons with severe mental illness in the United Kingdom. Psychiatr. Serv. 2007;58:405–408
  23. Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, et al. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring). 2009;17:713–722
  24. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220–233
  25. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1995;52:219–229
  26. Weiden PJ, Mackell JA, Mcdonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr. Res. 2004;66:51–57

PII: S0165-0327(10)00281-8

doi: 10.1016/j.jad.2010.02.138

Journal of Affective Disorders
Volume 126, Issue 1 , Pages 75-79 , October 2010

Article Tools